These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31995280)

  • 1. Design, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents.
    Ananth AH; Manikandan N; Rajan RK; Elancheran R; Lakshmithendral K; Ramanathan M; Bhattacharjee A; Kabilan S
    Chem Biodivers; 2020 Feb; 17(2):e1900659. PubMed ID: 31995280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.
    Bajaj S; Kumar MS; Tinwala H; Yc M
    Bioorg Chem; 2021 Jun; 111():104873. PubMed ID: 33845381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents.
    Lakshmithendral K; Saravanan K; Elancheran R; Archana K; Manikandan N; Arjun HA; Ramanathan M; Lokanath NK; Kabilan S
    Eur J Med Chem; 2019 Apr; 168():1-10. PubMed ID: 30798049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha.
    Kaur K; Verma H; Gangwar P; Jangid K; Dhiman M; Kumar V; Jaitak V
    Bioorg Chem; 2024 Jun; 147():107341. PubMed ID: 38593531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents.
    Bajaj S; Roy PP; Singh J
    Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells.
    Dhawan S; Kerru N; Awolade P; Singh-Pillay A; Saha ST; Kaur M; Jonnalagadda SB; Singh P
    Bioorg Med Chem; 2018 Nov; 26(21):5612-5623. PubMed ID: 30360952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and cytotoxicity screening of 5-aryl-3-(2-(pyrrolyl) thiophenyl)-1, 2, 4-oxadiazoles as potential antitumor molecules on breast cancer MCF-7 cells.
    Abd El Hameid MK; Mohammed MR
    Bioorg Chem; 2019 May; 86():609-623. PubMed ID: 30807934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents.
    El Mansouri AE; Oubella A; Maatallah M; AitItto MY; Zahouily M; Morjani H; Lazrek HB
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127438. PubMed ID: 32736079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
    Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
    Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Screening of 5-Aryl-3-(2-(pyrrolyl)thiophenyl)-1,2,4-oxadiazoles as Potential Antitumor Molecules on Breast Cancer MCF-7 Cell Line.
    Abd El Hameid MK
    Chem Pharm Bull (Tokyo); 2018 Dec; 66(12):1181-1195. PubMed ID: 30298827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and Antitumor Activity of Novel 5-Pyridyl-1,3,4-oxadiazole Derivatives against the Breast Cancer Cell Line MCF-7.
    Khalil NA; Kamal AM; Emam SH
    Biol Pharm Bull; 2015; 38(5):763-73. PubMed ID: 25947922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and docking studies of novel 4-aminophenol-1,2,4-oxadiazole hybrids as apoptosis inducers against triple negative breast cancer cells targeting MAP kinase.
    Dhanalakshmi B; Anil Kumar BM; Srinivasa Murthy V; Srinivasa SM; Vivek HK; Sennappan M; Rangappa S
    J Biomol Struct Dyn; 2024 Jul; 42(11):5841-5857. PubMed ID: 37529915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents.
    El Mansouri AE; Oubella A; Mehdi A; AitItto MY; Zahouily M; Morjani H; Lazrek HB
    Bioorg Chem; 2021 Mar; 108():104558. PubMed ID: 33358270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An
    Malkaje S; Srinivasa MG; Deshpande N S; Navada S; Revanasiddappa Bc
    Curr Drug Res Rev; 2023; 15(1):88-100. PubMed ID: 36017854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
    Acar Çevik U; Celik I; Işık A; Ahmad I; Patel H; Özkay Y; Kaplancıklı ZA
    J Biomol Struct Dyn; 2023 Mar; 41(5):1944-1958. PubMed ID: 35037830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.
    Shahzad SA; Yar M; Bajda M; Jadoon B; Khan ZA; Naqvi SA; Shaikh AJ; Hayat K; Mahmmod A; Mahmood N; Filipek S
    Bioorg Med Chem; 2014 Feb; 22(3):1008-15. PubMed ID: 24411198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
    Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
    Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
    Sun J; Zhu H; Yang ZM; Zhu HL
    Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
    Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
    Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New indenopyrazole linked oxadiazole conjugates as anti-pancreatic cancer agents: Design, synthesis, in silico studies including 3D-QSAR analysis.
    Khan I; Ganapathi T; Rehman MM; Shareef MA; Kumar CG; Kamal A
    Bioorg Med Chem Lett; 2021 Jul; 44():128094. PubMed ID: 33964437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.